PRESS RELEASE published on 10/19/2023 at 07:00, 2 years 8 months ago Sartorius Stedim Biotech SA: Nine-month results 2023 of Sartorius Stedim Biotech
PRESS RELEASE published on 10/19/2023 at 07:00, 2 years 8 months ago Sartorius Stedim Biotech SA: Résultats de Sartorius Stedim Biotech pour les neuf premiers mois de 2023
PRESS RELEASE published on 10/12/2023 at 21:05, 2 years 8 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech publie ses résultats préliminaires pour les 9 premiers mois de l’année et revoit ses prévisions à la baisse pour 2023
PRESS RELEASE published on 10/12/2023 at 21:05, 2 years 8 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
PRESS RELEASE published on 10/04/2023 at 10:02, 2 years 8 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
PRESS RELEASE published on 10/04/2023 at 10:02, 2 years 8 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 09/01/2023 at 15:38, 2 years 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 09/01/2023 at 15:38, 2 years 9 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
PRESS RELEASE published on 08/01/2023 at 14:08, 2 years 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 08/01/2023 at 14:08, 2 years 10 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 06/20/2026 at 01:00, 2 days 5 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 6 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 2 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 5 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 06:05, 32 minutes ago adidas and GLO Brands B.V., debuts ADIDAS PRO WORK, a new safety footwear range, combining performance, protection and style for the modern worksite
Published on 06/22/2026 at 04:05, 2 hours 32 minutes ago Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 9 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 2 days ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 10 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:33, 2 days 11 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 11 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 11 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 11 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
